SYMBOL:

    Up to 100 tickers separated by a space .....Watch Pre-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CYTRX CORPORATION
(NQSC:CYTR Last Sale: 2.37 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (CYTR : $2.37)
$223 million Market Cap at September 12, 2013
Employs 23.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

11726 San Vicente Boulevard Research Report Earnings Snapshot - Last 08/06/17
Los Angeles, CA 90049 Fact Sheet
Phone: 310-826-5648 Financial Statements
Peer Comparison
Annual Reports

Steven A. Kriegsman, Pres./CEO, Mitchell K. Fogelman, CFO
Focus in the area of small molecules and ribonucleic acid interference (RNAi). Spun-off RXi Pharmaceuticals unit (RXII) March 11, 2008, issuing 1 RXi share for every 20.05 shares of CytRx.
Historical Charts    Technical Analysis
No Historical Data available for CYTR

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CYTR $2.37 $ 0 $2.36 $2.387 85,742 $1.59 $4.15 93,978
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $222,728

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
25-MAY-04 CYTRE Symbol Changed to CYTR
21-APR-04 CYTR Symbol Changed to CYTRE
05-FEB-96 CYTR Split 1 for 4

A173
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex